Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Stem Cells (Dayton, Ohio)|June 15, 2013
Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesisPasquale Pellegrini, Pellegrini Pasquale, Alex Cordero, et al.
Breast Cancer Research and Treatment|April 19, 2017
Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expressionMonica E Reyes, Takeo Fujii, Daniel Branstetter, et al.
Immunology and Cell Biology|September 18, 2018
The immune checkpoint CD96 defines a distinct lymphocyte phenotype and is highly expressed on tumor-infiltrating T cellsAilin Lepletier, Viviana P Lutzky, Deepak Mittal, et al.
Nature Medicine|June 21, 2016
RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriersEmma Nolan, François Vaillant, Daniel Branstetter, et al.
Geburtshilfe Und Frauenheilkunde|January 5, 2024
RANK and RANKL Expression in Tumors of Patients with Early Breast CancerAnnika Behrens, Lena Wurmthaler, Felix Heindl, et al.
Oncoimmunology|June 15, 2018
Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasisHeidi Harjunpää, Stephen J Blake, Elizabeth Ahern, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2023
NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophagesDongchen Yuan, Jing Hu, Xiaoman Ju, et al.
The Journal of Clinical Investigation|May 15, 2018
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanismsXian-Yang Li, Indrajit Das, Ailin Lepletier, et al.
Pageof 7